Steven Lang, Ph.D., MBA, Vice President, Biologics
Dr. Lang is responsible for Aragen’s Bioproduction, Cell Line Development and Analytical groups. Prior to joining Aragen, Dr. Lang was with Genentech’s Cell Culture department as a Director overseeing research material generation, cell line development, automation, and CHO process development covering activities from DNA to Phase 2 clinical supplies. In addition to his functional role, Dr. Lang led an initiative to modernize the CMC scientific data management processes. This work spawned numerous digitization efforts across the global Roche Technical Development network to drive efficiency, transparency and compliance. He also acted as a CMC leader for a project team delivering an innovative bispecific antibody into clinical trials. Prior to Genentech, Steve was with Janssen and Johnson & Johnson. Dr. Land received his Ph.D. in Molecular Microbiology from State University of New York Stony Brook. He then undertook post-doctoral work at Stony Brook and Johnson & Johnson Pharmaceutical R&D. He received his MBA from Rider University.